Diabetes Care Curriculum
The course will prepare pharmacists to improve and provide pharmaceutical care to diabetic patients. Upon completion of the course, pharmacists will understand the pathophysiology of diabetes and the goals of therapy, and be able to assess and monitor diabetic patients, working with other healthcare providers to adjust medications and improve patient outcomes.
|
|
|
|
Hour |
Topic |
|
1 Jan 17 |
Course Introduction - orientation to the course, participant expectations, etc. This session will review the course operations and requirements. At the conclusion of this session, pharmacist participants should be able to: - state the
requirements for successful completion of the course - state the
requirements for ACPE and certificate credit - access the
internet course materials INSTRUCTOR: Peter J. Rice, PharmD, PhD |
|
2 |
Pathogenesis of Diabetes - development of disease - pathological changes - development of sequelae - monitoring disease progression This presentation will review diabetes as a disease,
and the progression of the disease in the untreated or poorly treated
patients. General goals of therapy
will be presented, particularly for blood glucose control; specific treatment
recommendations for hypertension, cholesterol, ophthalmic and renal
complications will be presented in later sessions. At the conclusion of this session,
participants should be able to: - describe
the underlying pathology for type I and type II diabetes - describe
the presentation of diabetes - describe
the progression of diabetes - state the
general treatment goals for diabetes INSTRUCTOR: Alan N. Peiris , MD, PhD, MRCP, FACP, FACE |
|
3 |
Epidemiology of Diabetes & Public Health Issues Pharmacists and Diabetes - the This presentation will review some of the research
and epidemiological studies which underlie and support the provision of
pharmaceutical care to diabetic patients and show that aggressive treatment
of diabetes can improve quality of life and prolong patient survival. - review
background supporting aggressive treatment of diabetes - define the
objectives of pharmaceutical care of diabetics - state the
major results of the Asheville Diabetes Project INSTRUCTOR: Michael Hayter – Wellmont |
|
4 Jan 24 |
Diabetes Standards of Care This session will prepare pharmacists to understand the current standard of care for diabetes patients and to monitor diabetic care. At the conclusion of this session, participants should be able to: -
state and explain the goals for diabetic care, including blood glucose
control, cholesterol, physician
visits, lab testing, examination for co-morbidities, and immunization … -
using a list of diabetic care requirements, review patient information
and determine the need for diabetic care -
develop a pharmaceutical care plan for diabetic patients -
document services provided to diabetic patients INSTRUCTOR: Peter J. Rice, PharmD, PhD |
|
5 |
Patient Assessment This session will provide pharmacist participants with the background and skills to assess diabetic patients . At the conclusion of this session, participants should be able to perform testing required for diabetes care, including: - scripted patient
interview - blood
pressure - weight INSTRUCTOR: TBA |
|
6 |
Measurement of Blood Glucose - counseling and use of glucose meters - use of glucose meter software and Analysis of blood glucose results and alteration of therapy This presentation will review the changes in blood
glucose which accompany diabetes, and monitoring of blood glucose. At the conclusion of this session,
participants should be able to: -
state normal and diagnostic values for fasting and postprandial blood
sugar -
explain the physiologic control and clinical significance of
hemoglobin A1C -
graph typical 24 hour blood sugar levels in healthy, prediabetic and
diabetic patients -
appropriately instruct patients on sampling blood glucose, saving
results to meter memory, and disposing of sharps -
graph actual blood glucose values using meter software -
recognize blood glucose values supporting alteration of therapy INSTRUCTOR: pharmacist needed |
|
7 Jan 31 |
Reimbursement MSHA Diabetes Care Program Medicare Part D Other Diabetes Programs This session will provide the practical information needed to participate in diabetes care and apply for reimbursement. Breakout sessions may be needed, based on the number of separate diabetes care programs. At the conclusion of this session, participants should be able to: - state the
participation requirements for the program(s) - state the
patient contact / counseling requirements - file a
claim for reimbursement - INSTRUCTOR: Timothy W. Coffey, PharmD (JCMCH) |
|
8 |
LAB: preparation and analysis of blood glucose
results This session will allow participants to gain
experience with blood glucose meters and presentation of data. Participants will collect their own blood
glucose sample at defined times, save the results on a glucose meter, upload
the results to computer, graph the results using meter software, create a
report, and note recommendations for additional patient care. Additionally, participants will obtain
blood glucose results from a diabetic patient. At the conclusion of this session, participants should be able to: - understand
the burden of blood glucose measurement by patients - use a glucose meter and accompanying software INSTRUCTOR: TBA |
|
9 |
Pharmacology of
Insulins This session will review the pharmacology of insulin in its various formulations and routes of administration. At the conclusion of this session, participants should be able to: - state the
pharmacological actions of insulin - recognize
the activity differences between various insulins - graph the
insulin activity over time for various insulins - describe
two approaches for control of blood sugar by insulin - INSTRUCTOR: Donald B. Hoover, PhD |
|
10 Jan 31 |
Pharmacology of
Oral Diabetic Medications This session will review the pharmacology of drugs other than insulin for controlling blood glucose. At the conclusion of this session, participants should be able to: - state the
mechanism of action of each drug - describe
the effect of each drug on blood glucose - state the
pharmacological actions of each drug - describe
the common adverse effects of each drug - describe
how drugs are combined in effective drug therapy - INSTRUCTOR: Donald B. Hoover, PhD |
|
11 |
Written Exam |
|
12 |
Pharmacotherapy of
Diabetes - planning and adjusting insulin regimens - planning and adjusting oral diabetes medications This session will review the principles of using
insulin and/or oral diabetic drugs to control blood glucose. At the conclusion of this session,
participants should be able to: - instruct
patients on administering insulin - instruct
patients on using oral diabetic medications - recognize
appropriate pharmacotherapy for diabetes - recognize
inappropriate pharmacotherapy for diabetes - make
protocol-based recommendations for adjusting therapy INSTRUCTOR: pharmacist (preferred) or physician needed |
|
13 |
Medication Review
in Diabetes Care This session will review the principles and practice of diabetes management in the presence of other disease states. At the conclusion of this session, participants should be able to: -
review patient medications to determine optimal therapy -
recognize problem medications in diabetic patients -
recognize additional treatment requirements for diabetic patients with
concomitant disease states -
make recommendations for initiating or adjusting pharmacotherapy INSTRUCTOR: Peter J. Rice, PharmD, PhD (tentative) |
|
14 Feb 7 |
LAB: planning and adjusting insulin and oral
diabetic medications This workshop session will allow participants to
gain experience with monitoring patient blood glucose data and following
protocols for patient care. Pharmacist
participants will receive four to six patient cases which may require
intervention. Additionally,
participants will obtain similar data from their diabetic patient. At the conclusion of this session, participants should be able to: - review
patient data, including blood glucose measurements and effects of
pharmacotherapy - identify
problems and propose adjustments to pharmacotherapy - make
protocol-based changes to therapy - counsel
diabetic patients on their medications INSTRUCTOR: TBA |
|
15 |
Diabetes
Complications – cardiovascular - special standards - exercise plans GOAL: know treatment standards, This presentation will review cardiovascular aspects
of diabetes, including CV complications of the disease and recommendations
for treatment of hypertension and high cholesterol. At the conclusion of this session,
participants should be able to: - describe
the cardiovascular effects of diabetes - state the
goals of hypertension therapy in diabetic patients - state the
goals of cholesterol therapy in diabetic patients - describe
the role of exercise in various diabetic patients - interpret
patient data and decide whether treatment goals are appropriate - interpret
patient data and determine if goals are being met - counsel and
refer patients to physician when appropriate INSTRUCTOR: Chris Downs, MD ?? |
|
16 |
Diabetes
Complications – neuropathy - how do we prevent and treat diabetic neuropathy LAB: patient case reports This presentation will review neural aspects of
diabetes, including diabetic neuropathy and its complications, such as
foot problems. At the conclusion of
this session, participants should be able to: -
describe the effects of diabetes on nerve transmission -
-
interpret patient data and decide whether treatment goals are
appropriate -
interpret patient data and determine if goals are being met -
INSTRUCTOR: TBA |
|
17 Feb 14 |
Patient Assessment
– skin care, wounds and feet Preferably with on-site patients This session will allow participants to gain
experience with monitoring patients with circulatory and neuropathic changes
in the lower extremities. Pharmacist
participants will review two to four patients who may require
intervention. Additionally,
participants will obtain similar data from their diabetic patient. At the conclusion of this session, participants should be able to: - examine and
assess patients with diabetic foot issues - recognize
conditions requiring physician referral - counsel
diabetic patients on foot care INSTRUCTOR: MSHA diabetes care nurse |
|
18 |
Diabetic Nutrition - counting carbs - determining insulin requirements - participants do calculations - counseling patients on nutrition This session will provide participating pharmacists with a modest background in nutrition, particularly as it relates to diabetic patients . At the conclusion of this session, participants should be able to: - determine
insulin requirements - perform
calculations related to carbohydrates and insulin - counsel
patients on nutrition and support nutritional recommendations of primary care
providers INSTRUCTOR: Garren Woodby, PharmD, CDE or
Timothy Coffey, PharmD |
|
19 |
Diabetes
Complications – nephropathy - patient assessment and counseling - how do we alter therapy - what medications delay nephropathy This presentation will review renal aspects of
diabetes, including renal failure and electrolyte disturbances. At the conclusion of this session, pharmacist participants
should be able to: -
describe the renal effects of diabetes -
state the drugs that are appropriate for prevention of the renal
complications of diabetes -
describe the development of diabetic ketoacidosis, signs and
appropriate medical response -
interpret patient data and decide whether treatment goals are
appropriate -
interpret patient data and determine if goals are being met INSTRUCTOR: Leslie W. Panus, MD |
|
20 Feb 21 |
Diabetes
Complications – ocular - how do pharmacists manage diabetes patients This presentation will review ophthalmic aspects of
diabetes, including complications of the disease and recommendations for
treatment of ocular disorders in diabetic patients. At the conclusion of this
session, pharmacist participants should be able to: - describe
the ophthalmologic effects of diabetes - state
standards for ocular exams and treatment in diabetic patients - counsel
patients on common eye problems - recognize
ocular problems that require physician referral - INSTRUCTOR: TBA |
|
21 |
Successful patient
counseling This session will provide inspiration and ideas that will enable and encourage pharmacists to improve pharmaceutical care to diabetic patients. At the conclusion of this session, participants should be able to: - develop a
diabetes care plan using previous knowledge -
successfully encourage patients to improve their management of
diabetes - document
provided services INSTRUCTOR: TBA |
|
22 |
Improving patient
compliance in diabetes patients This session will . At the conclusion of this session, participants should be able to: - state some
techniques for motivating patients with diabetes - improve
patient compliance through counseling, referral and monitoring of therapy INSTRUCTOR: TBA |
|
23 |
Written Exam |
|
24 |
Practical Exam |
|
25 - 30 |
up to an additional credit (6 hrs) for course readings and projects |
|
|
|
The course will be offered through the ETSU Pharmacy Continuing Education program. It will be approximately 30 hours in length, including reading assignments, and will be offered as a weekly live evening course of three hours over eight weeks. There will be two written exams and a practical exam consisting of two patient cases requiring intervention and counseling by pharmacist participants. All participants will receive pharmacy continuing education credit; pharmacists successfully completing the written and practical exams will receive additional credit as an ACPE certificate course.
The course materials will be available on a blackboard website to allow students to access reading materials and slide-audio lectures during the course.
Faculty
Faculty will include basic scientists and clinical practitioners with expertise in diabetes and diabetes care. Ideally, faculty will provide both scientific and practical expertise in a teaching format that actively involves participants and encourages the development of critical thinking skills and sound clinical judgment.
Medical Letter Treatment Guidelines (2002) and (2005)
Medical Letter (2006) Glulisine insulin
Am J Health-Syst Pharm formulary reviews
Treatment Guidelines
diabetes
diabetic neuropathy
diabetic nephropathy
cholesterol
hypertension
heart failure